// App-Quantinova.ai

PO‐054 : A positive 18F‐FDG PET/CT scan at the end of R‐CHOP in diffuse large B cell lymphoma patients has a low positive predictive value for relapse

Researchers

Presenter

  • C Hildyard

Principal Investigators

  • M Subesinghe

  • S Rashid

  • R Farnell

  • G Collins

Medical Centers

  • Hematology

  • Nuclear Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • 18F-fluorodeoxyglucose

  • DNA Damage Inducible Transcript 3

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Prednisolone

  • Vincristine

  • Rituximab

Outcome

  • N/A

Study Design

  • Superiority

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved